Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.
暂无分享，去创建一个
N. Ciccarelli | M. Colafigli | A. De Luca | A. Borghetti | S. Di Giambenedetto | S. Giambenedetto | M. Fabbiani | R. Cauda | R. Gagliardini | A. Mondi | A. D’Avino | A. D. Luca | R. Cauda